The DermaLaserTM is a low-level laser (LLLT). This laser works in the non ablative 405nm Violet light spectrum. This spectrum of light works for acne by killing the bacteria P. Acnes (Propionibacterium) that causes acne. Unlike current acne-laser treatments, the DermaLaserTM is not high density, or hot, so it does not irritate or adversely affect the healthy skin cells. The DermaLaserTM isolates and targets the acne-causing bacteria itself, not the skin, so it effectively treats the cause of acne at its root. The DermaLaserTM by Erchonia has received FDA approval for the treatment of acne.

Up until now, people with acne have had to rely on strong antibiotic treatments, topical ointments or hot lasers. Research shows that side-effects from low-level laser treatments of all kinds are minimal to non-existent and the DermaLaserTM is no exception.

The DermaLaserTM works because a porphyrin (Coproporphyrin III) produced within P. Acnes generates free radicals when irradiated by the 405nm wavelength of light. Particularly when applied over series of treatments, these free radicals ultimately kill the bacteria. Since porphyrins are not otherwise present in skin, and no UV light is employed, it is safe, and has been licensed by the U.S. FDA.

The treatment works even better if used with red visible light (636 nm) resulting in a 76% reduction of lesions after 3 months of daily treatment for 80% of the patients.

Erchonia, the company that created DermaLaserTM, is the leader in low-level laser technology. DermaLaserTM is the latest in a series of low-level laser treatments that are used for everything from pain relief, hair regeneration to aiding in liposuction surgery.

The DermaLaserTM Acne treatment offers a safe, effective and non-toxic option to standard medical protocols that prescribes high-risk drugs like Acutane, and hot lasers. During your skin care consultation our staff will help you determine your best and most effective treatment options.

Treatment: The treatment process is painless and leaves no residual irritation, redness or swelling. The general protocol is six minutes of DermaLaserTM applied to the three major regions on the face, which include areas of the forehead and both cheek areas. Smaller areas such as the nose, chin or temple each require three minutes of treatment. Patients should have at least two sessions a week for approximately six weeks to obtain results. Our consultant may suggest a third treatment per week for the first 6 weeks if the case is severe. Positive results typically become apparent by the third week of treatment.

Follow-up: Our clinical aesthetician and laser specialist will provide the best solutions for your continued skin care. Maintaining your regimen of care will help you keep the results that you have worked so hard for.